KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Common Equity (2016 - 2026)

Exelixis (EXEL) has 17 years of Common Equity data on record, last reported at $2.2 billion in Q1 2026.

  • For Q1 2026, Common Equity fell 3.69% year-over-year to $2.2 billion; the TTM value through Jan 2026 reached $2.2 billion, down 3.69%, while the annual FY2026 figure was $2.2 billion, 3.69% down from the prior year.
  • Common Equity reached $2.2 billion in Q1 2026 per EXEL's latest filing, roughly flat from $2.2 billion in the prior quarter.
  • Across five years, Common Equity topped out at $2.6 billion in Q1 2023 and bottomed at $2.0 billion in Q3 2025.
  • Average Common Equity over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2023.
  • Peak YoY movement for Common Equity: increased 20.02% in 2022, then fell 16.72% in 2024.
  • A 5-year view of Common Equity shows it stood at $2.5 billion in 2022, then fell by 9.02% to $2.3 billion in 2023, then increased by 0.51% to $2.3 billion in 2024, then dropped by 5.04% to $2.2 billion in 2025, then grew by 0.03% to $2.2 billion in 2026.
  • Per Business Quant database, its latest 3 readings for Common Equity were $2.2 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.0 billion in Q3 2025.